Financial Advisor: Sale of Acadia Shares at 27.90 SAR

GIB Capital announced the completion of the full sale of Acdema's stake in the Saudi Pharmaceutical Industries and Medical Appliances Company (SPIMED) at a price of 27.90 SAR per share. The sale was executed through the negotiated deals mechanism, with a total of 12,588,173 shares offered, representing 10.49% of the company's capital. This transaction resulted in Acdema fully exiting its ownership stake in SPIMED, marking a strategic shift in the company's ownership structure.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل